Ordering Recommendation

Preferred test for genetic confirmation of Wilson disease or determination of carrier status.

Mnemonic

ATP7B NGS

Methodology

Massively Parallel Sequencing

Performed

Varies

Reported

3 weeks

New York DOH Approval Status

Specimens from New York clients will be sent out to a New York DOH approved laboratory, if possible.

Specimen Required

Patient Preparation
Collect

Lavender (EDTA) or Yellow (ACD Solution A or B).

Specimen Preparation

Transport 3 mL whole blood. (Min: 2 mL)

Storage/Transport Temperature

Refrigerated.

Unacceptable Conditions

Serum or plasma; grossly hemolyzed or frozen specimens

Remarks
Stability

Ambient: 72 hours; Refrigerated: 1 week; Frozen: Unacceptable

Reference Interval

By report.

Interpretive Data

Refer to report.   

This test was developed and its performance characteristics determined by ARUP Laboratories. It has not been cleared or approved by the U.S. Food and Drug Administration. This test was performed in a CLIA-certified laboratory and is intended for clinical purposes.

Counseling and informed consent are recommended for genetic testing. Consent forms are available online.

Compliance Category

Laboratory Developed Test (LDT)

Note

Gene tested: ATP7B (NM_000053)
The Sardinian founder variant, c.-436_-422del15 is not evaluated, and deletion/duplication analysis is not available for this gene.

Hotline History

N/A

CPT Codes

81406

Components

Component Test Code* Component Chart Name LOINC
3004412 Wilson Disease (ATP7B) Specimen
3004413 Wilson Disease (ATP7B) Interp
* Component test codes cannot be used to order tests. The information provided here is not sufficient for interface builds; for a complete test mix, please click the sidebar link to access the Interface Map.

Aliases

  • ATP7B
  • hepatolenticular degeneration
  • Wilson disease
Wilson Disease (ATP7B) Sequencing